Problems and prospects in the use of lymphoma idiotypes as therapeutic targets
- 1 January 1988
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 41 (S3) , 9-12
- https://doi.org/10.1002/ijc.2910410803
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Emergence of immunoglobulin variants following treatment of a B cell leukemia with an immunotoxin composed of antiidiotypic antibody and saporin.The Journal of Experimental Medicine, 1987
- Induction and enhancement by monocytes of antibody-induced modulation of a variety of human lymphoid cell surface antigensBlood, 1985
- Emergence of Idiotype Variants during Treatment of B-Cell Lymphoma with Anti-Idiotype AntibodiesNew England Journal of Medicine, 1985
- Preparation and properties of FabIgG, a chimeric univalent antibody designed to attack tumour cellsBioscience Reports, 1985
- Mechanisms of tumour cell escape encountered in treating lymphocytic leukaemia with anti-idiotypic antibodyBritish Journal of Cancer, 1984
- In vivo and in vitro uptake and degradation of acetylated low density lipoprotein by rat liver endothelial, Kupffer, and parenchymal cells.Journal of Biological Chemistry, 1983
- Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype AntibodyNew England Journal of Medicine, 1982
- Univalent antibodies kill tumour cells in vitro and in vivoNature, 1982
- Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfacesBritish Journal of Cancer, 1980
- Myeloma Proteins as Tumor-Specific Transplantation AntigensProceedings of the National Academy of Sciences, 1972